 |
FDA Approval Activities for this Drug
Optiray (ioversol injection),74%, 68%, 51% Mallinckrodt Medical, NDA 20-923 IOVERSOL Injection 34% OPTIRAY 160 Mallinckrodt
019710 IOVERSOL Injection 51% OPTIRAY 240 Mallinckrodt
020923 IOVERSOL Injection 64% OPTIRAY 300 Mallinckrodt
019710 IOVERSOL Injection 64% OPTIRAY 300 Mallinckrodt
019710 IOVERSOL Injection 68% OPTIRAY 320 Mallinckrodt
020923 IOVERSOL Injection 74% OPTIRAY 350 Mallinckrodt
019710 IOVERSOL Injection 74% OPTIRAY 350 Mallinckrodt
For the most up-to-date approval information, please locate this API using the drug index.
|